Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Canada flag Canada · Delayed Price · Currency is CAD
0.1700
+0.0200 (13.33%)
Mar 21, 2025, 3:43 PM EST
142.86%
Market Cap 27.39M
Revenue (ttm) n/a
Net Income (ttm) -1.53M
Shares Out 152.15M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,496
Average Volume 104,629
Open 0.1700
Previous Close 0.1500
Day's Range 0.1700 - 0.1700
52-Week Range 0.0400 - 0.2450
Beta 0.42
RSI 64.74
Earnings Date Mar 24, 2025

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada. [Read more]

Sector Healthcare
CEO Brent Willis
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.